A call to arms
In April 2020 Armstrong Medical’s Chairman John Armstrong received a phone call from the Cabinet Office with a plea for industry to assist in the fight against Covid19.
Less than two weeks prior to receiving the call Armstrong Medical completed construction of our new 26,000 sq ft warehouse extension. This additional warehouse space facilitated the rapid construction of a 2,700 sq ft temporary cleanroom assembly area allowing us to meet the increased demand.
A changed business
As we entered week commencing 16th March 2020 Armstrong Medical employed 160 people whilst holding an order book of 100,000 units. On 23rd March 2020 UK lockdown was announced. Over the following weeks in response to the global Covid19 pandemic, employment rapidly grew to 360 employees. Orders peaked at 900,000 units, more than 9 times our average.
Over this 12-week period significant infrastructure investment, exceeding £360,000, enabled us to respond to increased demand.
Realising our company vision to become the global preferred partner supporting healthcare professionals to SAVE LIVES in acute respiratory care.
Armstrong Medical’s devices featured in both National and International media, our first generation FD140 CPAP device featured in Spanish media and BBC program ‘Coronavirus: One week in one hospital’.
In addition, Armstrong Medical engaged with international companies involved in rapid production of ventilators including Dyson and Babcock International.
Introducing Armstrong Medical’s FD140i
Following the Global success of the FD140 high flow and CPAP device, ‘Project Alpha’-development of the 2nd generation FD140i commenced in 2018. This project was in the final stages as we entered the Global pandemic and approval for sale was granted on 22nd May 2020.
The FD140i will be manufactured at our Coleraine facility bringing immediate employment of 6 and a further 9 positions as anticipated Global demand is realised.
‘Project Alpha’ production facility was officially opened on 4th June 2020 by Secretary of State Brandon Lewis.
Investing in the Future
Further investment has been approved by the board for product development totalling £400 000, manufacturing infrastructure of £1.5 million and an additional warehouse extension to facilitate a new cleanroom facility £2 million. Build to commence by Autumn of 2020.